Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cel-Sci edges up on false release

CVM was up $0.02 to $0.32 on 1.3 million shares

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE